Meet the Founder
Paul Suri, MHA, BA
Founder, AMLAPure
From Pharmaceutical Research to Botanical Ingredient Science
Paul Suri's path to founding AMLAPure did not begin in the supplement industry.
It began in pharmaceutical research.
Suri began his pharmaceutical career as an employee of Pfizer and later transitioned into independent consulting, initially continuing work with Pfizer.
His subsequent consulting and research-and-development experience involved organizations including Johnson & Johnson, Amgen and Novartis.
Working in pharmaceutical research created an enduring respect for structured investigation, documentation, evidence and an equally important question:
What does the available evidence actually establish?
Years later, that question would become central to AMLAPure.
A Personal Change in Direction
The transition from pharmaceutical research toward botanical and nutritional science was not simply a business decision.
It became personal when Paul's father developed dementia.
Paul cared for his father as the disease progressed and confronted the limitations of the pharmacological options available to his father at that time.
The experience changed the direction of Paul's interests.
It did not lead him to conclude that plants, mushrooms, extracts or nutritional products could treat or reverse dementia.
Instead, it raised a much broader question:
What else can we learn about food, plants and naturally occurring compounds that may contribute to nutrition, wellness and quality of life?
That question redirected his attention toward botanical ingredients, mushrooms, plant extracts, food-based nutrition and the scientific literature surrounding them.
Returning to Research From a Different Direction
Paul approached botanical science with many of the same questions that had shaped his earlier research career.
What is the evidence?
How was the study designed?
Was the research conducted in cells, animals or humans?
What ingredient was actually studied?
What dose or concentration was used?
Was the material whole botanical, an extract or an isolated compound?
Can the findings reasonably be applied to a finished formulation?
These questions became increasingly important because botanical research is complex.
A plant name alone does not fully characterize an ingredient.
Species, plant part, growing conditions, processing, extraction method, concentration and standardization can all matter.
The Ingredient That Changed the Direction: AMLA
One botanical became particularly important to this investigation:
Amla — Phyllanthus emblica, or Indian gooseberry.
At first, the question appeared simple.
What is amla, and why has this fruit attracted scientific interest?
But investigating amla produced a much larger realization.
Not all ingredients carrying the same botanical name are necessarily equivalent.
Amla could appear as fresh fruit, whole-fruit powder, juice-derived material or botanical extract.
Extracts themselves could differ.
The deeper Paul investigated the ingredient, the less satisfactory it became to simply see “amla” on a label and assume the question had been answered.
That experience helped establish a principle that would eventually become central to AMLAPure:
The ingredient name is only the beginning.
For the detailed botanical story, see What Is Amla (Indian Gooseberry)?.
From Curiosity to AMLAPure
The investigation of amla eventually expanded into a broader examination of botanical ingredients.
Questions about amla led to questions about:
Whole botanical material versus extracts
Extract ratios and concentration
Phytochemical composition
Ingredient processing
Standardization
Analytical testing
Functional enzymes
Measured enzyme activity
Formulation design
Those questions became part of the intellectual foundation for AMLAPure.
But the company was not intended to abandon pharmaceutical research principles in favor of botanical tradition.
The objective was almost the opposite:
Apply greater scientific discipline to understanding botanical and nutritional ingredients.
Research Interests Beyond Individual Supplements
Paul's research interests have continued beyond individual products.
Areas of scientific curiosity have included phytochemicals, botanical extracts, viruses, membrane permeability and permeation, and the gut-brain axis.
These are research interests—not claims that AMLAPure products have been demonstrated to diagnose, treat, cure or prevent conditions associated with these areas.
That distinction reflects Paul's broader approach:
Interesting science should create better questions before it creates stronger claims.
Research Without Overstatement
One of the principles Paul brought from pharmaceutical research into AMLAPure is the importance of distinguishing different levels of evidence.
A laboratory experiment can provide useful mechanistic information.
An animal study can generate important hypotheses.
An observational study can identify associations.
A randomized human clinical trial can answer a different class of question.
A systematic review can evaluate a larger body of evidence.
But these forms of evidence are not interchangeable.
Likewise, research involving an isolated phytochemical cannot automatically be attributed to an entire botanical.
Research involving one extract cannot automatically be attributed to every extract of the same plant.
And research on individual ingredients cannot automatically establish the effects of a finished multi-ingredient formulation.
This is why AMLAPure emphasizes:
Research without overstatement.
From Founder Research to Ingredient Science
As AMLAPure developed, Paul's original ingredient research expanded into what is now the AMLAPure Ingredient Science Library.
The objective is to examine ingredients individually before asking readers to understand them as components of larger formulations.
The library includes research and education covering botanical ingredients, functional enzymes, phytochemicals and formulation components.
It also allows AMLAPure to discuss an ingredient's scientific literature separately from the commercial product containing it.
That separation matters.
Ingredient education should remain ingredient education.
Product formulation is a related—but different—question.
Explore the AMLAPure Ingredient Science Library.
From AMLA to a Broader Formulation Philosophy
AMLA became the starting point, but AMLAPure did not stop with one botanical.
The investigation expanded into nattokinase and the importance of characterizing enzymes through measured activity.
It expanded into additional botanical and enzyme ingredients.
Eventually, those separate areas of investigation contributed to a broader formulation philosophy and the development of the Enterinex platform.
The complete company and formulation evolution belongs in the AMLAPure story rather than Paul's biography.
Read Our Story: From AMLA to Enterinex.
Or explore Enterinex: The Evolution of the AMLAPure Formulation System.
The Principle Behind AMLAPure
After a career that began in pharmaceutical research and eventually moved into botanical ingredient science, Paul's approach can be summarized by a relatively simple principle:
Understand what the ingredient actually is before deciding what to say about it.
That means looking beyond the front of the label.
It means distinguishing whole botanical material from extracts.
It means understanding what an extract ratio does—and does not—tell us.
It means distinguishing milligram weight from enzyme activity.
It means examining phytochemicals without assuming that the presence of a compound establishes a clinical outcome.
And it means separating scientific curiosity from demonstrated evidence.
Those principles continue to guide the development of AMLAPure.
Continue Exploring
Read Our Story.
Explore the AMLAPure Ingredient Science Library.
Explore Research & Testing.
Learn about Enterinex